Go Pro

BioLife Solutions (BLFS) 10K Form and Latest SEC Filings 2026

BioLife Solutions logo
$35.04 -0.41 (-1.16%)
As of 03:17 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Latest BioLife Solutions SEC Filings & Recent Activity

BioLife Solutions (NASDAQ:BLFS) has submitted 1,022+ documents to the U.S. Securities and Exchange Commission (SEC) since 2017. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in BioLife Solutions's financial statements. The most recent filing was a Form 10-Q submitted on August 6, 2026.

Form 4
BIOLIFE SOLUTIONS INC Reports Ownership Change on Jul. 21, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
BioLife Solutions Files Current Report on Aug. 3, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-Q
BioLife Solutions Files Quarterly Report on Aug. 6, 2026

The 10-Q contains BioLife Solutions's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

BioLife Solutions SEC Filing History

Browse BioLife Solutions' complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
08/06/2026 3:22 PM
BioLife Solutions (834365) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/03/2026 4:15 PM
BioLife Solutions (834365) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/22/2026 4:17 PM
BioLife Solutions (834365) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/22/2026 3:09 PM
BioLife Solutions (834365) Subject
REPLIGEN CORP (730272) Filed by
Form 425
07/21/2026 5:47 PM
BioLife Solutions (834365) Issuer
Werner Sean (2047541) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/13/2026 4:03 PM
Berard Todd (1633186) Reporting
BioLife Solutions (834365) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/13/2026 4:03 PM
BioLife Solutions (834365) Issuer
Mathew Aby J. (1556355) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/13/2026 4:03 PM
BioLife Solutions (834365) Issuer
Wichterman Troy (1892616) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2026 3:50 PM
BioLife Solutions (834365) Issuer
Mathew Aby J. (1556355) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2026 3:50 PM
BioLife Solutions (834365) Issuer
Wichterman Troy (1892616) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2026 3:50 PM
BioLife Solutions (834365) Issuer
DE GREEF RODERICK (1241181) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2026 3:50 PM
BioLife Solutions (834365) Issuer
Werner Sean (2047541) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2026 3:50 PM
Berard Todd (1633186) Reporting
BioLife Solutions (834365) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2026 4:01 PM
BioLife Solutions (834365) Issuer
Mathew Aby J. (1556355) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2026 4:01 PM
Berard Todd (1633186) Reporting
BioLife Solutions (834365) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2026 4:01 PM
BioLife Solutions (834365) Issuer
Wichterman Troy (1892616) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2026 5:36 PM
BioLife Solutions (834365) Subject
Casdin Capital, LLC (1534261) Filed by
Form SCHEDULE 13G
06/03/2026 7:03 AM
BioLife Solutions (834365) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2026 5:37 PM
BioLife Solutions (834365) Subject
Casdin Capital, LLC (1534261) Filed by
Form SCHEDULE 13D/A
05/21/2026 6:10 PM
BioLife Solutions (834365) Issuer
Casdin Capital, LLC (1534261) Reporting
Casdin Eli (1534264) Reporting
Casdin Partners GP, LLC (1534260) Reporting
Casdin Partners Master Fund, L.P. (1534265) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2026 6:04 PM
BioLife Solutions (834365) Subject
Casdin Partners Master Fund, L.P. (1534265) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/20/2026 6:26 PM
BioLife Solutions (834365) Subject
Casdin Partners Master Fund, L.P. (1534265) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/19/2026 5:25 PM
BioLife Solutions (834365) Subject
Casdin Partners Master Fund, L.P. (1534265) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/15/2026 9:06 AM
BioLife Solutions (834365) Subject
T. Rowe Price Investment Management, Inc. (1897612) Filed by
Form SCHEDULE 13G/A
05/07/2026 3:18 PM
BioLife Solutions (834365) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2026 2:41 PM
BioLife Solutions (834365) Subject
Invesco Ltd. (914208) Filed by
Form SCHEDULE 13G/A
04/28/2026 4:12 PM
BioLife Solutions (834365) Filer
Form 10-K/A
04/10/2026 4:29 PM
BioLife Solutions (834365) Issuer
Wichterman Troy (1892616) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2026 4:29 PM
Berard Todd (1633186) Reporting
BioLife Solutions (834365) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2026 4:29 PM
BioLife Solutions (834365) Issuer
Mathew Aby J. (1556355) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/31/2026 4:19 PM
BioLife Solutions (834365) Issuer
Foster Karen A. (1683151) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2026 3:11 PM
BioLife Solutions (834365) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
03/23/2026 4:08 PM
BioLife Solutions (834365) Issuer
Mathew Aby J. (1556355) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2026 4:08 PM
BioLife Solutions (834365) Issuer
Foster Karen A. (1683151) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2026 4:08 PM
Aebersold Sarah (1837756) Reporting
BioLife Solutions (834365) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2026 4:08 PM
BioLife Solutions (834365) Issuer
Wichterman Troy (1892616) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2026 4:08 PM
BioLife Solutions (834365) Issuer
Werner Sean (2047541) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2026 4:09 PM
Berard Todd (1633186) Reporting
BioLife Solutions (834365) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2026 4:09 PM
BioLife Solutions (834365) Issuer
DE GREEF RODERICK (1241181) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2026 3:38 PM
BioLife Solutions (834365) Subject
Foster Karen A. (1683151) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/09/2026 5:11 PM
BioLife Solutions (834365) Issuer
Foster Karen A. (1683151) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
The cat is out the bag (Ad)

Almost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered separation packages to 8,500 workers, and Oracle is reportedly eliminating up to 30,000 positions. Goldman Sachs estimates 12,400 Americans are being financially displaced every single day. Analyst Porter Stansberry says the real driver runs deeper than AI - and two Nobel Prize winners have issued the same warning. He calls it the Final Displacement, and he's releasing a full investigation with specific companies to buy and sell before the next wave hits.tc pixel

Watch Porter Stansberry's full investigation into the Final Displacement now
03/09/2026 3:38 PM
BioLife Solutions (834365) Subject
Foster Karen A. (1683151) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2026 4:10 PM
Berard Todd (1633186) Reporting
BioLife Solutions (834365) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2026 4:10 PM
Aebersold Sarah (1837756) Reporting
BioLife Solutions (834365) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2026 4:10 PM
BioLife Solutions (834365) Issuer
Wichterman Troy (1892616) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2026 4:10 PM
BioLife Solutions (834365) Issuer
Mathew Aby J. (1556355) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2026 4:10 PM
BioLife Solutions (834365) Issuer
Foster Karen A. (1683151) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2026 4:10 PM
BioLife Solutions (834365) Issuer
Werner Sean (2047541) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2026 3:52 PM
BioLife Solutions (834365) Subject
Foster Karen A. (1683151) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2026 4:55 PM
BioLife Solutions (834365) Issuer
GOSWAMI JOYDEEP (1533115) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2026 4:55 PM
BioLife Solutions (834365) Issuer
Foster Karen A. (1683151) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2026 4:55 PM
BioLife Solutions (834365) Issuer
MOORE TIMOTHY L. (1669207) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2026 4:55 PM
BioLife Solutions (834365) Issuer
Werner Sean (2047541) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2026 4:55 PM
Aebersold Sarah (1837756) Reporting
BioLife Solutions (834365) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2026 4:55 PM
BioLife Solutions (834365) Issuer
Mathew Aby J. (1556355) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2026 4:55 PM
BioLife Solutions (834365) Issuer
DE GREEF RODERICK (1241181) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2026 4:55 PM
BioLife Solutions (834365) Issuer
Ellingson Rachel (1557271) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2026 4:55 PM
BioLife Solutions (834365) Issuer
Coste Catherine (1821432) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2026 4:56 PM
BioLife Solutions (834365) Issuer
Hunt Anthony (1606030) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2026 4:56 PM
BioLife Solutions (834365) Issuer
Wichterman Troy (1892616) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2026 4:56 PM
BioLife Solutions (834365) Issuer
DuRoss Amy (1854968) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2026 4:56 PM
Berard Todd (1633186) Reporting
BioLife Solutions (834365) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2026 1:48 PM
BioLife Solutions (834365) Subject
Invesco Ltd. (914208) Filed by
Form SCHEDULE 13G/A
01/12/2026 7:04 AM
BioLife Solutions (834365) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2026 4:03 PM
BioLife Solutions (834365) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2026 4:03 PM
Berard Todd (1633186) Reporting
BioLife Solutions (834365) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2026 4:04 PM
BioLife Solutions (834365) Issuer
Mathew Aby J. (1556355) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2026 4:04 PM
Aebersold Sarah (1837756) Reporting
BioLife Solutions (834365) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2026 4:04 PM
BioLife Solutions (834365) Issuer
Foster Karen A. (1683151) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2026 4:04 PM
BioLife Solutions (834365) Issuer
Wichterman Troy (1892616) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2026 11:15 AM
BioLife Solutions (834365) Subject
T. Rowe Price Investment Management, Inc. (1897612) Filed by
Form SCHEDULE 13G/A
12/17/2025 4:25 PM
BioLife Solutions (834365) Issuer
Foster Karen A. (1683151) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2025 4:25 PM
Berard Todd (1633186) Reporting
BioLife Solutions (834365) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2025 4:25 PM
BioLife Solutions (834365) Issuer
DuRoss Amy (1854968) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2025 4:26 PM
Aebersold Sarah (1837756) Reporting
BioLife Solutions (834365) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2025 4:26 PM
BioLife Solutions (834365) Issuer
Wichterman Troy (1892616) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2025 4:26 PM
BioLife Solutions (834365) Issuer
Mathew Aby J. (1556355) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2025 3:16 PM
Aebersold Sarah (1837756) Reporting
BioLife Solutions (834365) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/05/2025 5:44 PM
BioLife Solutions (834365) Issuer
Wichterman Troy (1892616) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2025 3:42 PM
BioLife Solutions (834365) Subject
Wichterman Troy (1892616) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/28/2025 4:39 PM
BioLife Solutions (834365) Issuer
DuRoss Amy (1854968) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/28/2025 4:35 PM
BioLife Solutions (834365) Issuer
Mathew Aby J. (1556355) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/28/2025 4:35 PM
BioLife Solutions (834365) Issuer
Werner Sean (2047541) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/28/2025 4:35 PM
BioLife Solutions (834365) Issuer
Foster Karen A. (1683151) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/28/2025 4:35 PM
Aebersold Sarah (1837756) Reporting
BioLife Solutions (834365) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/28/2025 4:35 PM
BioLife Solutions (834365) Issuer
Wichterman Troy (1892616) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/28/2025 4:35 PM
Berard Todd (1633186) Reporting
BioLife Solutions (834365) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2025 5:34 PM
BioLife Solutions (834365) Issuer
DuRoss Amy (1854968) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/17/2025 6:00 AM
BioLife Solutions (834365) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2025 4:18 PM
BioLife Solutions (834365) Issuer
DE GREEF RODERICK (1241181) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2025 7:46 AM
BioLife Solutions (834365) Subject
DE GREEF RODERICK (1241181) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
A $382 trillion migration and the position no one is talking about (Ad)

Trump just signed a law requiring America's entire $382 trillion financial system to migrate to a new money network by April 2027. BlackRock CEO Larry Fink already calls it 'the next major evolution in market infrastructure.' Our research has identified one small, overlooked position at the center of this policy-driven shift - already drawing quiet institutional buying from BNY Mellon, State Street, and JPMorgan. It currently trades for pennies relative to where institutional demand could push it. The Q3 2026 compliance deadline may be the last window before prices move.tc pixel

Click here to see the full research and the position name
11/06/2025 3:17 PM
BioLife Solutions (834365) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2025 3:08 PM
BioLife Solutions (834365) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2025 4:14 PM
BioLife Solutions (834365) Issuer
GOSWAMI JOYDEEP (1533115) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
10/24/2025 4:03 PM
BioLife Solutions (834365) Issuer
DE GREEF RODERICK (1241181) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2025 5:21 PM
BioLife Solutions (834365) Subject
DE GREEF RODERICK (1241181) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/22/2025 4:02 PM
BioLife Solutions (834365) Issuer
Werner Sean (2047541) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2025 6:55 PM
BioLife Solutions (834365) Issuer
Casdin Capital, LLC (1534261) Reporting
Casdin Eli (1534264) Reporting
Casdin Partners GP, LLC (1534260) Reporting
Casdin Partners Master Fund, L.P. (1534265) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2025 7:04 PM
BioLife Solutions (834365) Subject
Casdin Capital, LLC (1534261) Filed by
Form SCHEDULE 13D/A
10/16/2025 1:45 PM
BioLife Solutions (834365) Subject
GOSWAMI JOYDEEP (1533115) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)

BioLife Solutions SEC Filings - Frequently Asked Questions

BioLife Solutions (BLFS) has submitted 1,022+ filings to the SEC since 2017. You can browse the complete history or filter by form type using the tools above.

BioLife Solutions's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results. Key financial data from these reports is available on BioLife Solutions's financial statements page.

The most recent filing was a Form 10-Q submitted on August 6, 2026. This was a quarterly financial update for 2025.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NASDAQ:BLFS) was last updated on 8/18/2026 by MarketBeat.com Staff.
From Our Partners